within Pharmacolibrary.Drugs.ATC.D;

model D01AC06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 2.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.0008,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0011500000000000002,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Tiabendazole is an antifungal and anthelmintic agent, formerly used to treat infections caused by a variety of nematodes and fungi. It is less commonly used today due to the availability of safer or more effective agents, but may be used in certain clinical scenarios for treating strongyloidiasis and cutaneous larva migrans.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetics for healthy adult individuals after typical oral administration. No original pharmacokinetic publications with sufficient model detail were identified.</p><h4>References</h4><ol><li><p>Galtier, P, et al., &amp; Alvinerie, M (1994). Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep. <i>Experimental parasitology</i> 79(2) 166–176. DOI:<a href=&quot;https://doi.org/10.1006/expr.1994.1076&quot;>10.1006/expr.1994.1076</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7914496/&quot;>https://pubmed.ncbi.nlm.nih.gov/7914496</a></p></li><li><p>Stone, OJ, et al., &amp; Mullins, JF (1965). Effect of thiabendazole on Ancylostoma caninum. <i>Archives of dermatology</i> 92(1) 59–62. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11850956/&quot;>https://pubmed.ncbi.nlm.nih.gov/11850956</a></p></li><li><p>Jones, OA, et al., &amp; Griffin, JL (2013). Comparisons of metabolic and physiological changes in rats following short term oral dosing with pesticides commonly found in food. <i>Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association</i> 59 438–445. DOI:<a href=&quot;https://doi.org/10.1016/j.fct.2013.06.041&quot;>10.1016/j.fct.2013.06.041</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23822974/&quot;>https://pubmed.ncbi.nlm.nih.gov/23822974</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D01AC06;
